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Background: Stress granules (SG) have been 
implicated in the formation of pathological FUS 
and TDP-43 inclusions.  
Results: SG recruitment of FUS and TDP-43 
requires cytosolic mislocalization and their main 
RNA binding domain and glycine-rich domain.  
Conclusion: FUS and TDP-43 have similar 
requirements for SG recruitment. 
Significance: Understanding how FUS and TDP-43 
are recruited to SG is critical for understanding 
FTLD/ALS pathology.  
 
SUMMARY 
Cytoplasmic inclusions containing TAR DNA 
binding protein of 43 kDa (TDP-43) or Fused in 
sarcoma (FUS) are a hallmark of amyotrophic 
lateral sclerosis (ALS) and several subtypes of 
frontotemporal lobar degeneration (FTLD).  
FUS-positive inclusions in FTLD and ALS 
patients are consistently co-labeled with stress 
granule (SG) marker proteins.  Whether TDP-43 
inclusions contain SG markers is currently still 
debated. We determined the requirements for 
SG recruitment of FUS and TDP-43 and found 
that cytoplasmic mislocalization is a common 
prerequisite for SG recruitment of FUS and 
TDP-43.  For FUS, the arginine-glycine-glycine 
zinc finger domain, which is the protein´s main 
RNA binding domain, is most important for SG 
recruitment, while the glycine-rich domain and 
RNA recognition motif (RRM) domain have a 
minor contribution and the glutamine-rich 
domain is dispensable.  For TDP-43, both the 
RRM1 and the C-terminal glycine-rich domain 
are required for SG localization.  ALS-
associated point mutations located in the 
glycine-rich domain of TDP-43 do not affect SG 
recruitment.  Interestingly, a 25 kDa C-terminal 
fragment (CTF) of TDP-43, which is enriched in 
FTLD/ALS cortical inclusions but not spinal 
cord inclusions, fails to be recruited into SG.  
Consistently, inclusions in the cortex of FTLD 
patients, which are enriched for CTFs, are not 
co-labeled with the SG marker Poly A binding 
protein 1 (PABP-1), whereas inclusions in spinal 
cord, which contain full-length TDP-43, are 
frequently positive for this marker protein.   
 
Amyotrophic lateral sclerosis (ALS) and 
frontotemporal lobar degeneration (FTLD) are 
related neurodegenerative diseases, in which the 
majority of cases are characterized by the 
pathological accumulation of the TAR DNA 
binding protein 43 (TDP-43) or the Fused in 
 http://www.jbc.org/cgi/doi/10.1074/jbc.M111.328757The latest version is at 
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sarcoma (FUS) protein (1).  TDP-43 and FUS are 
DNA/RNA-binding proteins that are involved in 
transcriptional regulation, pre-mRNA splicing, 
microRNA processing and mRNA transport 
(reviewed in (2,3)).  Although both proteins exert 
their function predominantly in the nucleus, 
pathological TDP-43 and FUS inclusions are 
mostly observed in the cytoplasm.  Strikingly, 
inclusion-bearing cells often show a loss or 
reduction of nuclear TDP-43 or FUS staining (4-
11).  This has led to the hypothesis that loss of 
nuclear TDP-43 or FUS is a crucial step in disease 
progression.   
Both proteins have multiple RNA binding 
domains as well as a protein interaction domain 
predicted to have prion-like properties.  TDP-43 
has two RNA recognition motif (RRM) domains, 
RRM1 and RRM2, with RRM1 being the 
predominant functional RNA binding domain (12).   
In addition, TDP-43 contains a C-terminal glycine-
rich domain, which mediates interactions with other 
hnRNP proteins and is required for splicing 
regulation (13).  This domain is highly aggregation-
prone (14-18) and due to its amino acid 
composition has been suggested to have prion-like 
properties (19-22).  FUS has multiple RNA binding 
domains with arginine-glycine-glycine (RGG) 
motifs, a RRM domain and a zinc finger domain 
shown to mediate RNA binding (23,24).  In 
addition, FUS contains an N-terminal glutamine-
rich domain, which functions as a potent 
transcriptional activation domain (25) and was 
predicted to be a prion-like domain (19-21).   
The relevance of TDP-43 and FUS in the 
pathogenesis of ALS and FTLD was strongly 
supported by the discovery of autosomal dominant 
mutations within TARDBP (the gene encoding 
TDP-43) and FUS in familial forms of ALS (fALS) 
(6,7,26).  So far, almost 40 different TARDBP 
mutations have been reported, most of them are 
missense mutations in the glycine-rich C-terminal 
domain.  Although it has been claimed that 
TARDBP mutations increase aggregation tendency 
(14,15,27,28), alter the protein´s cellular 
localization (29-31) or alter the protein`s half-life 
and interactions with other proteins (32), the 
pathogenic mechanism of these mutations is still 
unclear, since many inconsistencies among 
different studies have been reported.  Pathogenic 
mutations in the FUS gene are mostly clustered in 
the C-terminal proline-tyrosine nuclear localization 
signal (PY-NLS) and impair Transportin-mediated 
nuclear import of FUS (33-36).  Interestingly, 
mutations that show a very severe nuclear import 
defect, such as P525L, cause an unusually early 
disease onset and rapid disease progression (37-39), 
suggesting that impaired nuclear import of FUS is 
causally linked to the disease (33,40).  Even though 
it is still unclear how reduced nuclear import of 
FUS leads to neurodegeneration, it has been shown 
that blockade of Transportin-mediated nuclear 
import or FUS mutations lead to recruitment of 
FUS into stress granules (SG), implicating SG and 
reduced nuclear transport in disease pathogenesis 
(33,34,36,40,41).  This is supported by the presence 
of SG markers in inclusions in ALS/FTLD-FUS 
patients (33,42). 
SG are cytosolic structures that form 
transiently upon exposure of cells to environmental 
stress, such as heat, viral infection, oxidative stress 
or hypoxia (43).  They arise from polysomes and 
store mRNAs encoding housekeeping proteins, but 
exclude mRNAs encoding chaperones and enzymes 
involved in damage repair.  In addition to mRNAs, 
SG contain many RNA binding proteins, such as 
Poly A binding protein 1 (PABP-1) and  T cell 
intracellular antigen 1 (TIA-1), which serve as 
specific markers for SG (44).  In cultured cells, SG 
formation can be elicited with a variety of stress 
treatments, such as heat shock (42-44°C), osmotic 
shock, UV irradiation or substances that elicit 
mitochondrial and/or oxidative stress (44).  SG 
have also been observed in vivo (41,45-47) and SG 
marker proteins were found to label the 
pathological FUS inclusions in post mortem brains 
of ALS/FTLD patients (33,42).  Thus, it has been 
suggested that SG might be the precursors of the 
pathological FUS inclusions in ALS/FTLD-FUS 
patients (33). 
How FUS is recruited to SG is currently 
unknown. Since FUS is an RNA binding protein, it 
is conceivable that it is recruited into these 
structures via its associated mRNAs.  Alternatively, 
protein-protein interactions might be involved in 
localization of FUS to SG.  Interestingly, TIA-1 
contains a prion-like glutamine-rich domain that 
has homology to the N-terminal glutamine-rich 
domain of FUS and promotes SG assembly by a 
prion-like aggregation mechanism (48,49).  
Whether this domain of FUS is required for SG 
recruitment or aggregation is still unknown.  
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TDP-43 has also been described to be 
recruited to SG under various stress conditions 
(31,50-55) and SG-associated proteins have been 
identified as TDP-43-interacting proteins (56).  
However, it is still controversial whether TDP-43 
inclusions in human patients contain SG markers.  
Two studies found a lack of SG markers in TDP-43 
inclusions of ALS/FTLD-TDP patients (33,50), 
while two other studies reported co-labeling of 
TDP-43 inclusions with SG markers (31,57).  
Furthermore, it is still not clear if or how TARDBP 
mutations affect SG recruitment.  One cell culture 
study reported that TARDBP mutations increase the 
number of cells with TDP-43 inclusions in response 
to stress (31), while another group found that 
mutant (R361S) TDP-43 impairs SG formation 
(54), and a third study reported that overexpression 
of mutant (G348C) TDP-43 leads to larger SG (51).   
To address how FUS and TDP-43 are 
recruited into SG, we mapped the domains required 
for SG recruitment of FUS and TDP-43.  In 
addition, we analyzed the effect of various fALS-
associated TARDBP mutations on SG recruitment 
of TDP-43 and further investigated the presence of 
SG marker proteins in TDP-43 inclusions in 
ALS/FTLD-TDP cortex and spinal cord. 
 
EXPERIMENTAL PROCEDURES 
Cell culture and transfection  Human 
cervical carcinoma cells (HeLa) were cultured in 
Dulbecco´s modified Eagle´s medium with 
Glutamax (Invitrogen) supplemented with 10% 
(vol/vol) fetal calf serum (Invitrogen) and 
penicillin/streptomycin (PAA).  Transfection of 
HeLa cells was carried out with Fugene 6 (Roche) 
or Lipofectamine 2000 (Invitrogen) according to 
the manufacturer´s instructions.  Hippocampal 
neurons were isolated from embryonic day 18 rats 
as described previously (58).  Neurons were plated 
at densities of 18 000 cells/cm2 in 6 cm tissue 
culture dishes containing poly-L-lysine (1 mg/ml; 
Sigma-Aldrich)-coated glass coverslips and 
Neurobasal medium supplemented with 2% B27 
and 0.5 mM glutamine (all from Invitrogen).  On 
day in vitro (DIV) 7, cultured neurons were 
transfected with FUS or TDP-43 constructs using 
Lipofectamine 2000 (Invitrogen) and were analyzed 
on DIV 9.  
Stress and inhibitor treatment  Heat shock 
was performed by incubating cells for 1 hour in a 
tissue culture incubator heated to 44°C.  For 
recovery experiments, cells were shifted back to 
37°C and incubated another 60 min.  Where 
indicated, cycloheximide (CHX, Sigma) was added 
at a concentration of 20 µg/ml immediately before 
shifting cells to 44°C.  Clotrimazole (Sigma C6019) 
was dissolved in DMSO (20 mM stock) and was 
added to cells under serum-free conditions in 
OptiMEM (Invitrogen) at a final concentration of 
20 M for 30 min.  Sodium (meta)arsenite (Sigma 
S71287) was dissolved in water (100 mM stock) 
and was added to cells at a final concentration of 
0.5 mM for 30 min.  
Antibodies  The following antibodies were 
used:  -Actin-specific mouse monoclonal antibody 
clone AC-74 (Sigma); GFP-specific rabbit 
polyclonal antibody (BD Living Colors); HA-
specific mouse monoclonal antibody HA.11 
(Covance); horseradish peroxidase (HRP)-coupled 
rat monoclonal anti-HA antibody 3F10 (Roche); 
myc-specific mouse monoclonal antibody 9E10 (sc-
40, Santa Cruz); PABP-1-specific rabbit polyclonal 
antibody (Cell Signaling); TDP-43-specific rabbit 
polyclonal antibody TARDBP (Proteintech); 
polyclonal antibodies raised against amino acid 
residues 6-24 of TDP-43 (N-t TDP-43) and amino 
acid residues 394-414 of TDP-43 (C-t TDP-43) 
(59); phospho-serine 409/410-specific TDP-43 rat 
monoclonal antibody clone 1D3 (60); TIA-1-
specific goat polyclonal antibody (C-20, Santa 
Cruz); -Tubulin-specific mouse monoclonal 
antibody clone B-5-1-2 (Sigma); β-Tubulin-
specific rabbit polyclonal antibody clone Tuj1 
(Sigma); V5-specific mouse monoclonal antibody 
(R960-25, Invitrogen).  Secondary antibodies for 
immunoblotting were HRP-coupled goat anti-
mouse or anti-rabbit IgGs (Promega).  For 
immunofluorescence stainings, Alexa-488, Alexa-
555, Alexa-594 and Alexa-647-conjugated donkey 
anti-mouse, anti-rabbit, anti-rat or anti-goat IgG 
(Invitrogen) were used.  
cDNA constructs and primers  HA-FUS-
WT, HA-FUS-P525L and GFP-Bimax were 
described in (33).  For FUS deletion constructs, the 
individual domains of FUS were amplified by PCR 
and PCR products were cloned into the 
pcDNA3.1/Hygro(-) vector (Invitrogen) via 
BamHI/XhoI restriction digest.  TDP-WT-V5, myc-
TDP-WT and TDP-1-173-V5 were described in 
(61).  For TDP-NLSmut, amino acids 82-84 of 
TDP-WT-V5 were mutated to alanine by 
QuikChange mutagenesis (Stratagene) as described 
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by (62).  ALS-associated point mutations (A315T, 
M337V and G348C) were introduced into myc-
TDP-WT or TDP-NLSmut-V5 by QuikChange 
mutagenesis (Stratagene).  NLSmut-C encoding 
amino acids 1-273 of human TDP-43 was amplified 
by PCR and after BamHI/XbaI restriction digest 
was cloned into the pcDNA6/V5-His vector 
(Invitrogen), which contained a stop codon between 
the V5 and the polyhistidine tag sequence.  GFP-
tagged constructs were generated by subcloning the 
respective sequences into pEGFP-C1 (Clontech).  
For all constructs, sequence integrity was verified 
by sequencing.  Oligonucleotides sequences are 
available upon request.   
Human post mortem tissue  Histological 
analysis included five cases of FTLD-TDP (FTLD-
TDP subtype A (n=2), subtype B (n=2) and subtype 
C (n=1) according to (63)) and four ALS cases with 
TDP-43 pathology.   
Immunocytochemistry and immunohisto-
chemistry  For immunocytochemistry of Hela 
cells, cells were fixed for 15 min in 4% 
paraformaldehyde in PBS, permeabilized for 5 min 
in 0.2% Triton X-100 with 50 mM NH4Cl and 
subsequently blocked for 20-30 min in 5%  donkey 
serum in PBSS (PBS with 0.1% saponin).  Cells 
were stained with the indicated primary and 
secondary antibodies diluted in 5% donkey serum 
in PBSS for 30 min and were washed three to five 
times in PBSS.  To visualize nuclei, cells were 
stained with TO-PRO-3 iodide (Invitrogen, 1:500 in 
PBS) for 15 min and were washed three times in 
PBS.  Coverslips were mounted onto glass slides 
using ProLong Gold Antifade Reagent (Invitrogen).   
For immunocytochemistry of hippocampal 
neurons, neurons were fixed with 4% 
paraformaldehyde on DIV 9, quenched in 50 mM 
ammonium chloride for 10 min and permeabilized 
with 0.1% Triton X-100 for 3 min.  After blocking 
with 2% fetal bovine serum (Invitrogen), 2% 
bovine serum albumin (Sigma-Aldrich), and 0.2% 
fish gelatin (Sigma-Aldrich) dissolved in PBS, 
neurons were incubated with respective primary 
and secondary antibodies diluted in 10% blocking 
solution.  4’-6-diamidino-2-phenyl-indol (DAPI, 
Invitrogen) was used as a nuclear counterstain.   
Immunohistochemistry on human post 
mortem material was performed on 5 m thick 
sections of formalin-fixed, paraffin-embedded 
sections from spinal cord or hippocampus with the 
N- and C-terminal TDP-43-specific antibodies and 
anti-PABP-1 using the NovoLink™ Polymer 
Detection Kit (Novocastra) and developed with 
3,3'-diaminobenzidine.  Microwave antigen retrieval 
was performed for all stainings.  Double-label 
immunofluorescence for PABP-1 and pTDP-43 was 
performed using Alexa-488 and -594 conjugated 
secondary antibodies.  DAPI (Vector Laboratories) 
was used for nuclear counterstaining.  
Image acquisition and quantification  
Confocal images were obtained with an inverted 
laser scanning confocal microscope (Zeiss Axiovert 
200M) with a 63x/1.4 N.A. oil immersion lens, 
using a pinhole diameter of 1 Airy unit in the red 
channel.  Pictures were taken and analyzed with the 
LSM 510 confocal software (Zeiss).  For HeLa 
cells, single confocal images were taken in the 
plane of the largest cytosolic area.  For neurons, a 
series of images along the z axis was taken and 
projected into a single image using the maximal 
projection tool of the LSM 510 software.  
Immunofluorescence images of brain sections were 
obtained by wide-field fluorescence microscopy 
(BX61 Olympus with digital camera F-view, 
Olympus).   
Nuclear and cytosolic localization was 
quantified with the LSM 510 colocalization tool as 
described in (33).  Stress granule localization was 
quantified with Image J as follows:  Image identity 
was blinded and FUS or TDP-43 (green)/TIA-1 
(red) double positive cytoplasmic granules as well 
as the entire cell were manually encircled to 
measure fluorescence intensities of the green 
channel.  After background subtraction, the 
percentage of FUS or TDP-43 in SG was 
calculated.  For each condition, 10-20 cells were 
analyzed.  Means across all cells and standard 
deviations were calculated.  
Cell lysates and immunoblotting  Total cell 
lysates were prepared in ice cold 
radioimmunoprecipitation assay (RIPA) buffer 
freshly supplemented with complete EDTA-free 
protease inhibitor cocktail (Roche) for 15 min on 
ice.  Lysates were sonicated in a bioruptor 
(Diagenode, 45 seconds on high) and protein 
concentration was determined by BCA protein 
assay (Pierce).  Equal amounts of protein were 
separated by SDS-PAGE, transferred onto a PVDF 
membrane (Immobilon-P, Millipore) and analyzed 
by immunoblotting using the indicated antibodies.  
Bound antibodies were detected with the 
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chemiluminescence detection reagents ECL 
(Amersham) or Immobilon (Millipore).  
RNA binding assay  RNA binding of FUS 
and TDP-43 domains was determined in an in vitro 
RNA binding assay according to (24).  Briefly, 
proteins were in vitro transcribed and translated 
using the TNT T7 Coupled Reticulocyte Lysate 
System (Promega) and were labeled with 20 µCi 
[35S] methionine (Amersham Biosciences).  Strep-
Tactin sepharose (IBA) was blocked with 200 
µg/ml yeast tRNA (Roche) and 0.125 mg/ml bovine 
serum albumin (BSA, NEB) in wash buffer (10 mM 
Tris-HCl pH 7.4, 100 mM NaCl, 2.5 mM MgCl2, 
0.5 mM DTT, 0.5 mM EGTA, 0.5 % Triton X-100, 
10% glycerol) for 30 min at 4°C.  Afterwards, 
biotinylated RNA oligonucleotides (UG12: 
UGUGUGUGUGUGUGUGUGUGUGUG; GGUG: 
UUGUAUUUUGAGCUAGUUUGGUGAU or CCUC: 
UUGUAUUUUGAGCUAGUUUCCUCAU, all from 
Thermo Fisher Scientific) were bound to the 
preblocked sepharose beads.  Beads were rinsed 
twice with wash buffer and were incubated with 
radiolabeled samples for 10 min at 4°C in blocking 
buffer.  Beads were washed five times in wash 
buffer and boiled 5 min in Lämmli buffer.  Bound 
radiolabeled proteins were separated by SDS-
PAGE and visualized by fluorography.  10% of the 
radiolabeled sample was directly used for SDS-
PAGE and fluorography to visualize the input of 
radiolabeled protein. 
 
RESULTS 
The RGG-zinc finger domain of FUS is most 
important for SG recruitment, while the glutamine-
rich domain is dispensable  We and others 
previously found that cytosolically mislocalized 
FUS is recruited to SG upon cellular stress 
(33,34,41).  It is however still unknown whether 
cytosolic FUS is recruited into SG via its bound 
mRNAs or via protein-protein interactions, 
involving for example its TIA-1-related N-terminal 
domain, or even both.  To determine which 
domains are responsible for recruitment of FUS to 
SG, we expressed individual FUS domains in HeLa 
cells with an N-terminal HA-tag and analyzed their 
SG recruitment in comparison to full-length FUS 
(see Fig. 1A for a schematic diagram).  To this end, 
we introduced the P525L mutation into the PY-
NLS of the respective constructs, since this 
mutation causes cytosolic retention of FUS and 
allows its efficient recruitment to TIA-1-positive 
SG (33).  In contrast, constructs carrying a wild-
type (WT) PY-NLS were almost exclusively 
nuclear and hence were not recruited to SG upon 
cellular stress (Fig. S1).  
Initially, we investigated a variety of stress 
conditions, such as heat shock (44°C), oxidative 
stress caused by sodium arsenite treatment and 
mitochondrial stress caused by clotrimazole 
treatment, for their ability to induce SG formation.  
Consistent with our previous findings (33), FUS-
WT was located in the nucleus and therefore was 
not recruited to SG upon cellular stress (Fig. 1B, 
upper panels).  In contrast, FUS-P525L was 
efficiently recruited into SG under all stress 
conditions examined (Fig. 1B, lower panels).  FUS-
P525L-positive granules were bona fide stress 
granules, since they were co-localized with the SG 
marker TIA-1 and disassembled upon 
cycloheximide treatment or recovery from heat 
stress (Fig. S2A).  SG recruitment of FUS-P525L 
was not a cell type specific phenomenon, since it 
could also be observed in primary hippocampal 
neurons (Fig. 1C) and in SH-SY5Y neuroblastoma 
cells (Fig. S2B). 
Using heat shock as stress condition, we next 
examined how well the individual domains of FUS 
are recruited to SG (see schematic diagram in Fig. 
2A).  To obtain quantitative information, we 
measured the percentage of FUS protein localized 
in TIA-1 positive SG (see “experimental 
procedures” for details).  In contrast to full-length 
FUS-P525L, the glutamine-rich domain (Q) 
remained diffusely distributed in the cytosol after 
heat shock and no granular localization became 
evident, even though TIA-1-positive SG formed in 
transfected cells (Fig. 2B and C).  Thus, despite its 
homology to the prion-like domain of TIA-1 
(48,49), the Q domain of FUS does not seem to be 
involved in SG recruitment.  The glycine-rich 
domain (G) and the RRM domain (R) remained 
predominantly diffusely cytosolic, but small 
amounts were found in TIA-1-positive SG (Fig. 2B 
and C).  Finally, the C-terminal RGG-zinc finger 
domain (Z), which was rendered cytosolic by 
addition of the P525L mutation (ZP525L), showed 
more SG recruitment than all other domains 
examined.  Since the HA-tagged Q and ZP525L 
domain showed very weak expression compared to 
the other constructs and could not be detected by 
Western blot (Fig. S3), we expressed these 
apparently unstable domains as GFP fusion proteins 
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along with GFP-FUSP525L as a control.  This yielded 
higher expression levels (Fig. S4A) and confirmed 
that the ZP525L domain shows SG association, 
whereas the Q domain does not (Fig. S4B).  
Since our quantitative analysis revealed that 
none of the individual domains was recruited to SG 
to the same extent as the full-length protein (Fig. 
2C), we analyzed combinations of the three 
domains (RZP525L, GRZP525L and GR) and asked if 
this would enhance SG recruitment.  Indeed, the 
combination of these domains showed an additive 
effect compared to the individual domains (Fig. 2B 
and C), suggesting that all three domains contribute 
to SG recruitment.  Finally, we analyzed 
combinations of the Q domain with other domains 
(QGR, QG), to exclude that the Q domain might 
have a different effect in the context of the other 
domains.  However, QGR and QG did not differ in 
their SG localization from GR and G, respectively, 
demonstrating that the Q domain is indeed 
dispensable for SG recruitment.  Consistently, the 
GRZP525L protein, which lacks the Q domain, was 
recruited to SG equally well as full-length FUS-
P525L.  Furthermore, the relatively weak SG 
recruitment efficiency of the QGR protein confirms 
that the C-terminal Z domain plays the most 
important role for SG association of FUS.   
In summary, the RGG-zinc finger domain 
(Z) is the most important domain for SG 
recruitment of FUS.  The glycine-rich domain (G) 
and to a minor extent the RRM domain (R) also 
contribute to SG recruitment, whereas the prion-
like glutamine-rich domain (Q) is dispensable.  
The RGG-zinc finger domain is the main 
RNA binding domain of FUS – To explore if SG 
recruitment of the different FUS domains can be 
correlated with their ability to bind RNA, we 
examined their RNA binding capacity in an RNA 
binding assay.  To this end, we in vitro translated 
the same FUS constructs and performed a pull 
down assay with biotinylated RNA 
oligonucleotides immobilized on streptavidin 
beads.  Since FUS is known to preferentially bind 
to UG-rich sequences, specifically to 
oligonucleotides containing a GGUG motif (24), 
we first tested the ability of FUS-WT to bind to 
UG12 or a GGUG-containing oligonucleotide 
(UUGUAUUUUGAGCUAGUUUGGUGAU, named 
GGUG).  The same oligonucleotide with a CCUC 
motif (named CCUC) was used as a negative 
control.  Consistent with the previously reported 
finding that FUS binds to UG-rich sequences, FUS-
WT was efficiently pulled down by UG12 and to a 
lesser extent by GGUG, but not CCUC (Fig. 3A).   
Using UG12 as RNA bait, we next examined 
the RNA binding capacity of the individual FUS 
domains and combinations thereof (Fig. 3B).  This 
demonstrated that only proteins containing the Z 
domain (ZP525L, RZP525L and GRZP525L) showed 
efficient and selective binding to UG12 RNA.  (Note 
that compared to ZP525L, RZP525L and GRZP525L 
showed stronger signals already in the input gel and 
therefore signals obtained in the pulldown cannot 
be compared directly.)  In contrast, the Q, G and R 
domain and different combinations thereof (GR, 
QGR, QG) were not pulled down in our RNA 
binding assay, demonstrating that Q, G and R show 
no or only weak binding to UG12 RNA.  Thus, the 
C-terminal Z domain seems to be responsible for 
the preferential binding to UG-rich RNA.  
Interestingly, the domain with the highest RNA 
binding capacity (Z) was the one most important 
for SG recruitment (Fig. 2).  This correlation 
suggests that FUS might be recruited to SG by 
virtue of its RNA binding capacity.  The domains 
that contribute to SG recruitment to a lesser extent 
(G and R) showed no RNA binding capacity in our 
in vitro binding assay, suggesting that they might 
contribute to SG recruitment through other means, 
possibly protein-protein interactions. 
Cytosolic mislocalization is a prerequisite 
for SG recruitment of TDP-43 – Similar to FUS, 
TDP-43 has been described to be localized in SG 
under various experimental conditions (31,50-55).  
Since cytosolic mislocalization is a prerequisite for 
efficient SG recruitment of FUS (Fig. 1 and 
(33,41)), we speculated that this might also be the 
case for TDP-43.  To test this hypothesis, we 
mutated three essential amino acids of the classical 
bipartite nuclear localization signal (62) and 
analyzed SG recruitment of this artificial NLS 
mutant (NLSmut, see Fig. 4A for a schematic 
diagram) in comparison to wild-type TDP-43 
(TDP-WT) upon exposure to different stressors.  
TDP-WT was predominantly nuclear with and 
without stress and was not detectable in 
cytoplasmic granules (Fig. 4B, upper panels).  In 
contrast, the partially cytosolic NLSmut protein 
was readily detectable in TIA-1-positive SG upon 
heat shock, clotrimazole treatment and sodium 
arsenite treatment (Fig. 4B, lower panels).  TDP-
43-positive granules dissolved upon cycloheximide 
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treatment or recovery from heat stress (Fig. S5A), 
demonstrating that they are indeed SG and not 
protein aggregates.  Moreover, SG recruitment of 
NLSmut but not TDP-WT was observed in primary 
hippocampal neurons (Fig. 4C) and SH-SY5Y cells 
(Fig. S5B).  Thus, in all cell types examined, only 
cytosolic but not nuclear TDP-43 is efficiently 
recruited to SG. 
To corroborate this finding, we expressed an 
Importin  inhibitor peptide fused to GFP (GFP-
Bimax) (64) in HeLa cells.  Consistent with our 
previous findings (33), this caused endogenous 
TDP-43 to accumulate in the cytosol (Fig. 5).  In 
line with the view that cytosolic mislocalization of 
TDP-43 is required for SG recruitment, endogenous 
TDP-43 was detectable in heat shock-induced SG 
only when its nuclear import was blocked by 
expression of the GFP-Bimax inhibitor (Fig. 5).  In 
contrast, in control (GFP) transfected cells, TDP-43 
remained nuclear and was not detectable in SG 
upon heat shock.  Together these findings 
demonstrate that similar to FUS, SG recruitment of 
TDP-43 requires at least a partial mislocalization of 
the nuclear protein to the cytosol. 
ALS-associated TARDBP mutations do not 
affect nuclear localization or SG recruitment - 
Despite extensive research over the last few years, 
the pathogenic mechanism of ALS-associated 
TARDBP mutations remains unclear.  Some 
TARDBP mutations have been reported to cause 
cytosolic missorting of the protein (30,31), however 
this could not be confirmed in other studies 
(28,32,51).  Furthermore, it is still not clear if and 
how TARDBP mutations affect SG recruitment, 
since controversial findings have been reported 
(31,51,54).  
Since our data above imply that SG 
recruitment could be indicative of cytosolic 
mislocalization, we examined the localization of 
three well-studied ALS-associated TARDBP 
mutations (A315T, M337V and G348C) upon heat 
shock, to see if these mutants would be 
preferentially detected in SG.  However, none of 
the three examined ALS-associated point mutants 
showed detectable localization in TIA-1-positive 
SG upon heat shock (44°C), instead they were 
located entirely in the nucleus like TDP-WT (Fig. 
6A, for expression levels see Fig. 6B).  
Consistently, a quantification of the amount of 
nuclear/cytosolic TDP-43 in cells cultured under 
normal culture conditions (37°C) demonstrated that 
the three point mutants had an almost exclusive 
nuclear localization and did not differ from the WT 
protein (Fig. 6C).  Thus, the examined ALS-
associated TARDBP mutations (A315T, M337V 
and G348C) do not cause cytoplasmic 
mislocalization or SG recruitment of TDP-43. 
Since it is possible that TARDBP mutations 
may affect SG recruitment once the protein has 
accumulated in the cytosol, for example as a 
consequence of axonal injury (65) or reduced 
expression of nuclear import factors (66), we 
introduced the same ALS-associated TARDBP 
mutations into the NLS mutant of TDP-43, to see if 
the mutations would impair or enhance SG 
recruitment of cytosolic TDP-43.  As expected, 
TDP-NLSmutA315T, NLSmutM337V and NLSmutG348C 
showed the same cytosolic mislocalization as 
NLSmut (Fig. 7A, left panels) and similar 
expression levels (Fig. 7B).  Upon cellular stress 
elicited by clotrimazole treatment, all mutants were 
readily detectable in TIA-1-positive SG (Fig. 7A, 
right panels).  A quantitative analysis of SG 
recruitment showed that the ALS-associated 
TARDBP mutants were incorporated into SG to a 
similar degree as NLSmut (Fig. 7C).   
Taken together, the examined ALS-
associated point mutations in the glycine-rich C-
terminal domain of TDP-43 (A315T, M337V and 
G348C) neither cause cytosolic mislocalization of 
nuclear TDP-43, nor do they affect SG recruitment 
of cytosolic TDP-43.   
TDP-43 inclusions in spinal cord but not in 
cortex contain the SG marker PABP-1 – Even 
though TDP-43 can be recruited to SG under 
various experimental conditions (this study and 
(31,50,51,53,56)), it is still controversial whether 
TDP-43 inclusions in ALS/FTLD patients contain 
SG marker proteins.  Two studies showed a lack of 
SG markers in TDP-43 inclusions (33,50), while 
two other studies reported co-labeling of TDP-43 
inclusions with SG markers (31,57).  We reasoned 
that these discrepancies might be due to the fact 
that TDP-43 inclusions differ in their TDP-43 
species composition, with inclusions in the spinal 
cord of ALS and FTLD patients containing 
predominantly full-length TDP-43 and inclusions in 
the cortex and hippocampus of ALS and FTLD 
patients being highly enriched for C-terminal 
fragments (CTFs) of approximately 25 kDa (59,60). 
To see if differences in the TDP-43 species 
composition might account for the different results 
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regarding co-labeling of TDP-43 inclusions with 
SG markers, we stained sections of spinal cord or 
cortex (hippocampus) from ALS-TDP and FTLD-
TDP cases with N- and C-terminal TDP-43 
antibodies as well as antibodies specific for the SG 
marker protein PABP-1.  Inclusions in the spinal 
cord were consistently labeled with both N- and C-
terminal TDP-43 antibodies, while inclusions in the 
cortex, including those in dentate granule neurons, 
were only labeled with the C-terminal antibody 
(Fig. 8), confirming previous results (59).  Cortical 
TDP-43 inclusions were not immunoreactive for 
PABP-1, confirming our previous results (33).  
However, we revealed PABP-1 positivity in a 
subset (~66%) of TDP-43-positive inclusions in the 
spinal cord, as demonstrated by double-label 
immunofluorescence (Fig. 8 and Fig. S6).  Thus, 
TDP-43 inclusions in spinal cord and cortex show a 
differential co-labeling for the SG marker protein 
PABP-1. 
25 kDa C-terminal fragment (CTF) of TDP-
43 is not recruited to SG – We speculated that the 
differences in SG marker co-labeling of TDP-43 
inclusions in different tissues may be due to the 
presence of different TDP-43 species, with distinct 
abilities to be recruited to SG.  Since inclusions in 
cortex are highly enriched in CTFs of TDP-43 
(59,60) and are negative for PABP-1 (Fig. 8), we 
wondered if CTFs may be unable to associate with 
SG.  To test this hypothesis, we expressed a CTF of 
approximately 25 kDa (TDP1-173, see Fig. 9A for 
a schematic diagram) in HeLa cells and analyzed its 
recruitment to TIA-1-positive SG upon cellular 
stress.  Like NLSmut, TDP1-173 was partially 
localized in the cytosol under control conditions 
(Fig. 9B, left panels), since it lacks the N-terminal 
domain including the protein´s NLS (Fig. 9A).  
However, in contrast to NLSmut, TDP1-173 
remained diffusely distributed in the cytosol upon 
clotrimazole treatment and consistent with our 
hypothesis was very poorly incorporated into TIA-
1-positive SG (Fig. 9B, right panels and C).  Since 
TDP1-173 showed very low expression levels 
compared to NLSmut (Fig. 9D), we repeated the 
experiment with GFP-tagged TDP1-173, to 
exclude that the lack of SG association was simply 
due to low protein levels.  Similar to V5-tagged 
TDP1-173, the highly expressed GFP-tagged 
TDP1-173 remained diffusely distributed upon 
cellular stress (Fig. S7A and B).  Thus, independent 
of expression levels, the 25 kDa CTF fails to 
associate with SG.  This might explain why cortical 
TDP-43 inclusions, which are highly enriched in 
CTFs and contain little full-length TDP-43 (Fig. 8 
and (59,60)), are not co-labeled with SG marker 
proteins.   
The C-terminal glycine-rich domain of TDP-
43 is required for efficient SG recruitment – 
Surprisingly, not only deletion of amino acids 1-
173, but also deletion of the C-terminal glycine-rich 
domain from TDP-43 NLSmut (NLSmut-C, see 
schematic diagram in Fig. 9A) led to a strong 
reduction in SG recruitment, since NLSmut-C 
remained mostly diffusely distributed in the 
cytoplasm upon cellular stress (Fig. 9B and C).  
Expression level differences could not account for 
this effect, since NLSmut-C was at least as well 
expressed as NLSmut (Fig. 9D).  To test whether 
reduced RNA binding may be responsible for 
reduced SG recruitment of NLSmut-C, we 
performed an RNA binding assay using UG12 RNA 
as a TDP-43-specific target sequence (12).  As 
expected, TDP-WT was efficiently pulled down by 
UG12 (Fig. 10A).  Interestingly, TDP-WT bound 
equally well to GGUG but not the corresponding 
CCUC oligonucleotide, consistent with the recent 
finding that TDP-43 can bind to sequences other 
than UG repeats (67).   
Using UG12 as RNA bait, we next compared 
the RNA binding capacity of full-length TDP-43 
(WT and NLSmut) and the two deletion mutants 
NLSmutC and 1-173.  The full length proteins 
were specifically pulled down in our RNA binding 
assay, while TDP-1-173, which lacks the protein´s 
main RNA recognition motif (RRM1) (12), failed 
to bind to UG12 RNA (Fig. 10B), which might 
explain why this fragment is not recruited to SG in 
FTLD/ALS patients (Fig. 8) and in cultured cells 
(Fig. 9).  In contrast, NLSmut-C bound to UG12 
RNA as efficiently as full-length TDP-43 (Fig. 
10B), demonstrating that the reduced SG 
recruitment capacity of this deletion mutant cannot 
be explained by reduced RNA binding.  Thus, the 
glycine-rich domain seems to possess other, so far 
unknown features that are important for SG 
recruitment.   
In summary, RNA binding of TDP-43 
depends on the N-terminal RRM1 domain, but not 
the C-terminal glycine-rich domain.  Since both 
domains are required for SG recruitment of TDP-
43, we suggest that RNA binding plus additional 
features encoded in the C-terminal glycine-rich 
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domain, such as protein-protein interactions, might 
contribute to SG recruitment of TDP-43.   
 
DISCUSSION 
Two different mechanisms how FUS and TDP-43 
are recruited to SG can be envisaged:  First, since 
both proteins have multiple RNA binding motifs 
(12,24,68), it is conceivable that they are recruited 
into SG via bound mRNAs.  Second, protein-
protein interactions with other SG-associated 
proteins could be involved.  Our results suggest that 
RNA binding plays a crucial role for SG 
recruitment of both FUS and TDP-43, since 
deletion mutants lacking the principal RNA binding 
domains (Z domain of FUS and RRM1 domain of 
TDP-43) showed poor recruitment to SG.  This 
correlation between RNA binding and SG 
recruitment suggests that FUS and TDP-43 might 
be recruited into SG through binding to UG-rich 
RNA sequences (see model in Fig. 11), although 
we cannot exclude that protein-protein interactions 
mediated by the Z and RRM1 domain are involved 
as well.   
In addition, domains that did not bind to UG-
rich RNA in our in vitro assay (G and R domain of 
FUS and the C-terminal glycine-rich domain of 
TDP-43) seem to contribute to SG recruitment as 
well, since deletion of these domains impaired SG 
recruitment.  Given their lack of RNA binding, 
these domains may contribute to SG recruitment by 
providing protein-protein interactions with other 
SG proteins (symbolized by protein X and Y in Fig. 
11).  However, we cannot exclude that these 
putative protein-interacting domains bind to RNA 
sequences not represented in our in vitro binding 
assay and that these protein-RNA interactions 
contribute to SG recruitment.  Indeed, recent cross-
linking and immunoprecipitation (CLIP) 
experiments have shown that FUS can bind to AU-
rich stem loop structures (69) and TDP-43 can bind 
to sequences other than UG repeats (67).  Which 
domain(s) of FUS and TDP-43 mediate binding to 
these alternative target sequences remains to be 
investigated.  
Our finding that the C-terminal glycine-rich 
domain of TDP-43 (amino acid residues 274-414) 
is required for efficient SG recruitment is consistent 
with previously published data showing that 
residues 268-315 are necessary for localization of 
TDP-43 within SG (50,51).  Since the C-terminal 
domain has been reported to mediate protein-
protein interactions, such as interactions with other 
heterogenous ribonucleoproteins (hnRNPs) (13), 
including FUS (70), it seems likely that protein-
protein interactions contribute to SG recruitment of 
TDP-43, although the protein(s) involved remain to 
be identified (protein X in Fig. 11).  Freibaum and 
colleagues identified numerous proteins involved in 
translation and SG-associated proteins as TDP-43-
interacting proteins (56).  Furthermore, TDP-43 and 
TIA-1 were found to interact in co-
immunoprecipitation assays, however, this was 
only seen upon overexpression of both proteins 
(31).  Nevertheless, TIA-1 and other SG-associated 
proteins are obvious candidates for proteins that 
recruit TDP-43 into SG via its C-terminal domain.   
Although we did not observe myc- or V5-
tagged TDP-WT or endogenous TDP-43 in SG 
after various stress treatment (Fig. 4-7), it is 
possible that very small amounts of TDP-43, 
undetectable by our antibodies, are present in SG 
under these conditions.  That this might be the case 
is suggested by several reports describing at least 
small amounts of wild-type TDP-43 in SG upon 
various stress treatments (31,50,51,53,54,56).  
Nevertheless, we could show that an artificial 
mutation in the TDP-43 NLS (NLSmut) or 
inhibition of Importin -mediated nuclear import 
readily caused SG localization of TDP-43 upon 
cellular stress.  We therefore suggest that cytosolic 
mislocalization is a prerequisite for recruitment of 
TDP-43 into SG.  Cytosolic mislocalization may be 
artificially caused by high expression levels of 
TDP-WT and thus may allow unphysiological SG 
recruitment.  Under physiological expression levels 
we suggest that a nuclear import defect as the 
primary hit and cellular stress as the second hit are 
required for SG recruitment of TDP-43 (33,40).  In 
vivo, axonal injury (65) or reduced expression of 
nuclear transport factors, such as Cellular 
Apoptosis Susceptibility protein (CAS) and 
Importin-2 (66), might constitute such a primary 
hit leading to the cytoplasmic mislocalization of 
TDP-43 in ALS/FTLD-TDP patients.   
What remains enigmatic is the cellular 
mechanism of ALS-associated TARDBP mutations.  
In contrast to ALS-associated FUS mutations, 
TARDBP mutations in the glycine-rich C-terminal 
domain (A315T, M337V and G348C) did not affect 
nuclear localization in our study, consistent with 
previous reports (28,32,51).  Whether ALS-
associated TARDBP mutations affect SG formation 
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was controversial.  Two studies reported that 
TARDBP mutations increase the number or size of 
SG, suggesting a toxic gain-of-function mechanism 
(31,51), while another group found that R361S is a 
loss-of-function mutation with regard to SG 
formation, leading to fewer SG (54).  In our study, 
the percentage of TDP-NLSmut in SG was not 
significantly altered by the presence of ALS-
associated point mutations (A315T, M337V and 
G348C), despite the importance of the C-terminal 
domain for SG recruitment.  However, it remains 
possible that the dynamics of SG formation or 
dissolution are affected by ALS-associated 
TARDBP mutations, as recently suggested for 
R361S (54).   
Another dispute that has remained 
unresolved is whether TDP-43 inclusions in FTLD 
and ALS patients contain SG marker proteins or 
not.  Two studies reported a co-labeling of TDP-43 
inclusions with SG markers (31,57), while two 
other studies did not find evidence for SG marker 
co-labeling (33,50).  Our data suggest that SG 
marker co-labeling is dependent on the presence of 
full-length TDP-43, which is much more abundant 
in spinal cord inclusions than in cortical TDP-43 
inclusions (this study and (59,60)).  We therefore 
suggest that the reported discrepancies could be due 
to the presence of different TDP-43 species in 
inclusions in different regions of the central 
nervous system.  How CTFs are generated and why 
cortical TDP-43 inclusions are highly enriched in 
these fragments is still unclear.  The absence of SG 
markers from CTF-containing inclusions suggests 
that these inclusions either arise independently of 
SG or that CTFs dissociate from SG upon 
proteolytic cleavage of full-length TDP-43, 
presumably due to its reduced RNA binding 
capacity.  How exactly SG relate to CTF generation 
and TDP-43 inclusion formation remains to be 
investigated.   
The presence of SG marker proteins and 
RNA in pathological FUS or TDP-43 inclusions 
has led to the hypothesis that these inclusions could 
arise from stress granules (31,33,42,55).  Indeed, 
various forms of stress have been implicated in the 
pathogenesis of ALS, including oxidative stress, 
mitochondrial dysfunction, damage to the 
vasculature and inflammatory reactions (71-73).  
Even though it remains to be seen whether SG are 
actually pathogenic or protective, this model offers 
a plausible mechanism for how pathological 
aggregation of cytosolic FUS or TDP-43 might be 
triggered in response to cellular stress.  Recruitment 
into SG most likely increases the local FUS or 
TDP-43 concentration, which might seed 
aggregation of these otherwise soluble proteins in a 
prion-like manner (74).  Whether the prion-like 
domains of FUS and TDP-43 are secondarily 
involved in seeding aggregation remains to be seen.  
We would like to note that so far cellular models 
were unable to recapitulate bona fide FUS or TDP-
43 aggregation, since FUS or TDP-43-containing 
SG are rapidly disassembled upon stress removal 
((41) and this study).  We therefore believe that 
additional hits or chronic stress might be needed for 
irreversible aggregation of SG localized proteins 
(40). 
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FIGURE LEGENDS 
 
FIGURE 1.  Cytosolic FUS is recruited to SG upon treatment with various stressors.   
(A) Schematic diagram of FUS wild-type (WT) and P525L mutant used for transient transfection in HeLa 
cells.  HA = HA epitope tag; Q = glutamine-rich domain; G = glycine-rich domain; R = RNA recognition 
motif (RRM) domain; Z = arginine-glycine-glycine (RGG) zinc finger domain; PY = proline tyrosine 
nuclear localization signal (PY-NLS).   
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(B) HeLa cells were transiently transfected with N-terminally HA-tagged FUS-WT or FUS-P525L.  24 
hours after transfection, cells were subjected to heat shock (44°C for 1 hour), sodium arsenite (0.5 mM for 
30 min) or clotrimazole (20 µM for 30 min) or were left untreated (control).  Cells were fixed, stained with 
an HA-specific antibody (green), a TIA-1-specific antibody (red) and a nuclear counterstain (blue) and 
analyzed by confocal microscopy.  Panels to the right show a higher magnification of the boxed region.  
While FUS-WT remained nuclear, FUS-P525L was sequestered into SG under all stress conditions 
examined.  Scale bars: 20 µm. 
(C) Primary rat hippocampal neurons were transiently transfected with HA-FUS-WT or P525L on DIV 7.  
48 hours after transfection, neurons were subjected to heat shock (44°C) for 1 hour or left untreated (37°C).  
Neurons were fixed and stained with an HA-specific antibody (green), a TIA-1-specific antibody (red) and 
the neuronal marker antibody Tuj1 (white) to visualize neuronal morphology.  FUS-P525L showed 
cytoplasmic mislocalization and was recruited to TIA-1-positive SG upon heat stress.  Insets in the upper 
right corner show a higher magnification of the boxed region.  Scale bars: 20 µm.   
 
FIGURE 2.  The C-terminal RGG-zinc finger domain of FUS is the most important domain for SG 
recruitment. 
(A) Schematic diagram of different FUS constructs analyzed for SG recruitment.  The P525L mutation was 
introduced into the PY-NLS to obtain proteins mislocalized in the cytosol.  
(B) Immunocytochemistry of HeLa cells expressing the different FUS constructs shown in (A).  Prior to 
fixation, cells were subjected to heat shock (44°C for 1 hour) or left untreated (37°C).  Cells were stained 
with an HA-specific antibody (green), a TIA-1-specific antibody (red) and a nuclear counterstain (blue) and 
analyzed by confocal microscopy.  Panels to the right show a higher magnification of the boxed region.  
The Z domain is most important for SG recruitment, whereas the Q domain is dispensable.  The G and R 
domains also contribute to SG recruitment, but to a lesser extent than Z.  Scale bars = 20 µm.   
(C) The percentage of FUS localized in TIA-1-positive SG was quantified using ImageJ.  10-20 cells were 
analyzed in a blinded manner, means across all cells were calculated and standard deviations are indicated 
by error bars.  Note that the percentage of FUS-P525L in SG seems surprisingly low when looking at the 
corresponding confocal images in (B).  However, SG are very small compared to the remaining cellular 
volume and therefore FUS-P525L diffusely distributed in the cytosol and nucleus amounts to a significant 
percentage of the total protein (more than 80%). 
 
FIGURE 3.  The RGG-zinc finger domain of FUS binds to UG-rich RNA. 
(A) FUS-WT was in vitro translated in the presence of [35S]methionine (left lane, input) and was analyzed 
for binding to different RNA oligonucleotides immobilized on streptavidin beads (right lanes, UG12 = 
UGUGUGUGUGUGUGUGUGUGUGUG; GGUG = UUGUAUUUUGAGCUAGUUUGGUGAU; CCUC = 
UUGUAUUUUGAGCUAGUUUCCUCAU).  FUS was pulled down most efficiently by UG12 and to a lesser 
extent by GGUG RNA.  
(B) The indicated FUS constructs were in vitro translated in the presence of [35S]methionine (upper panel, 
input).  Biotinylated UG12 RNA immobilized on streptavidin beads was used to pull down radioactively 
labeled proteins (lower panel, pulldown).  CCUC RNA was used as a negative control.  FUS-WT and 
P525L and all proteins comprising the ZP525L domain were specifically pulled down by UG12 RNA, while 
the other proteins did not show detectable RNA binding.  Open arrowheads indicate degradation products.   
 
FIGURE 4.  Cytosolic mislocalization is a prerequisite for SG recruitment of TDP-43.   
(A) Schematic diagram of TDP-43 wild-type (WT) and NLS mutant (NLSmut).  NLSmut = triple point 
mutation in the classical nuclear localization signal (K83A/R84A/K85A); RRM = RNA recognition motif 
domain; G-rich = glycine-rich domain; V5 = V5 epitope tag. 
(B) C-terminally V5-tagged TDP-WT or NLSmut were transiently transfected into HeLa cells and 24 hours 
later were subjected to heat shock (44°C for 1 hour), sodium arsenite (0.5 mM for 30 min) or clotrimazole 
(20 µM for 30 min) treatment or were left untreated (control).  Cells were fixed, stained with a V5 (green) 
and TIA-1 (red)-specific antibody and a nuclear counterstain (blue) and analyzed by confocal microscopy.  
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Panels to the right show a higher magnification of the boxed region.  While the cytosolic NLS mutant was 
sequestered into SG, TDP-WT remained nuclear under all stress conditions examined.  Scale bars = 20 µm. 
(C) Primary rat hippocampal neurons were transiently transfected with V5-tagged TDP-WT or NLSmut. 48 
hours post-transfection, neurons were subjected to heat shock (44°C) for 1 hour or left untreated (37°C).  
Neurons were fixed and stained with a V5-specific antibody (green), a TIA-1-specific antibody (red) and 
the neuronal marker antibody Tuj1 (white) to visualize neuronal morphology.  NLSmut showed partial 
cytoplasmic mislocalization and was recruited to TIA-1-positive SG upon heat stress.  Insets in the upper 
right corner show a higher magnification of the boxed region.  Scale bars: 20 µm.   
 
FIGURE 5.  Endogenous TDP-43 is sequestered into heat shock-induced SG upon inhibition of 
Importin -dependent nuclear import. 
HeLa cells were transfected with an Importin α/β-specific peptide inhibitor fused to GFP (GFP-Bimax) or 
GFP as a control (green).  24 hours post-transfection cells were subjected to heat shock (44°C for 1 hour) or 
kept at control temperature (37°C) prior to fixation.  Cells were co-stained for endogenous TDP-43 (red) 
and TIA-1 (white) and analyzed by confocal microscopy.  Expression of GFP-Bimax resulted in cytosolic 
mislocalization of endogenous TDP-43 and recruitment into SG upon heat shock.  Under control conditions 
(GFP), TDP-43 was predominantly nuclear and did not colocalize with SG after heat shock.  Scale bars = 
20 µm. 
 
FIGURE 6.  ALS-associated TARDBP mutations do not alter the cellular localization of TDP-43. 
(A) Myc-tagged wild-type TDP-WT or TDP-43 carrying the indicated ALS-associated point mutations 
(A315T, M337V or G348C) were transiently transfected into HeLa cells.  24 hours post-transfection cells 
were subjected to heat shock (44°C for 1 hour) or kept at control temperature (37°C).  Afterwards cells 
were fixed, stained with a myc (green) and TIA-1 (red)-specific antibody and a nuclei counterstain (blue) 
and analyzed by confocal microscopy.  Both TDP-WT and the ALS-associated point mutants were nuclear 
under control conditions and remained nuclear upon heat shock.  Scale bars = 20 µm. 
(B) Expression level of TDP-43 constructs used in (A).  Total cell lysates were analyzed by 
immunoblotting with a myc-specific antibody (upper panel).  Tubulin served as a loading control (lower 
panel).  All lanes were from the same exposure of the same blot.  
(C) Quantification of nuclear and cytosolic fluorescence intensities of myc staining at 37°C.  Error bars 
indicate standard deviations.   
 
FIGURE 7.  ALS-associated TARDBP mutations do not affect SG recruitment of cytosolic TDP-43. 
ALS-associated point mutations (A315T, M337V, G348C) were introduced into the TDP-43 NLS mutant 
(NLSmutA315T, NLSmutM337V, NLSmutG348C) and effect of mutations on SG recruitment was analyzed. 
(A) HeLa cells transiently transfected with the indicated TDP-43 constructs were incubated with 
clotrimazole for 30 min or left untreated (control).  Cells were fixed, stained with a V5 (green) and TIA-1 
(red)-specific antibody and a nuclear counterstain (blue) and analyzed by confocal microscopy.  ALS-
associated point mutations did not affect SG recruitment of cytosolic TDP-43.  Scale bars = 20 µm. 
(B) Protein levels in total cell lysates were analyzed by immunoblotting with a V5-specific antibody (upper 
panel), Tubulin served as a loading control (lower panel).  Black arrowhead indicates full-length TDP-43, 
white arrowhead indicates caspase-generated 35 kDa C-terminal fragment (CTF) frequently observed under 
transient transfection conditions (61,75).   
(C) The percentage of TDP-43 localized in TIA-1-positive SG was quantified using ImageJ.  15-20 cells 
were analyzed in a blinded manner, means across all cells were calculated and standard deviations are 
indicated by error bars.   
 
FIGURE 8:  TDP-43 inclusions in spinal cord but not hippocampus are frequently co-labeled for the 
SG marker protein PABP-1. 
TDP-43 immunohistochemistry performed on formalin-fixed, paraffin-embedded tissue sections of spinal 
cord (upper panels) or hippocampus (lower panels) from FTLD-TDP and ALS-TDP cases.  Staining with 
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N-terminal and C-terminal TDP-43 specific antibodies demonstrated labeling of neuronal cytoplasmic 
inclusions in motor neurons in the spinal cord with both antibodies (ALS case #1 shown), whereas 
inclusions in dentate granule neurons in the hippocampus were labeled only with the C-terminal antibody 
(FTLD-TDP case #1 shown).  Double-label immunofluorescence stainings of the same cases showed co-
labeling of phospho-TDP-43 positive inclusions (green) with the SG marker protein PABP-1 (red) in the 
spinal cord, but not in cortical inclusions.  Nuclei were stained with DAPI (blue).  Scale bars = 10 µm. 
 
FIGURE 9.  25 kDa C-terminal fragment and a C-terminal deletion mutant of TDP-43 are poorly 
sequestered into SG.  
(A) Schematic diagram of TDP-43 deletion mutants analyzed for SG recruitment.  The deletion mutant 1-
173 was chosen to mimic the 25 kDa C-terminal fragment (CTF) found to be deposited in cortical regions 
of FTLD-TDP patients (4,59).  The C-terminal deletion mutant (NLSmutC) lacks the prion-like glycine-
rich domain.  
(B) The indicated TDP-43 constructs were transiently transfected in HeLa cells.  Prior to fixation, cells 
were treated with clotrimazole (20 µM, 30 min) or left untreated (control).  Subsequently, cells were stained 
with a V5 (green) and TIA-1 (red)-specific antibody and a nuclear counterstain (blue) and analyzed by 
confocal microscopy.  Panels to the right show a higher magnification of the boxed region.  In contrast to 
full length TDP-NLSmut, both deletion mutants remained predominantly diffuse in the cytosol upon heat 
shock and were poorly recruited to SG.  Scale bars = 20 µm.  
(C) The percentage of TDP-43 localized in TIA-1-positive SG was quantified using ImageJ.  15-20 cells 
were analyzed in a blinded manner, means across all cells were calculated and standard deviations are 
indicated by error bars.   
(D) Protein levels in total cell lysates were analyzed by immunoblotting with a V5-specific antibody (upper 
panel), Tubulin served as a loading control (lower panel).  Black arrowheads indicate full-length TDP-
NLSmut or the two deletion mutants, white arrowheads indicate degradation products.  All lanes were from 
the same exposure of the same blot.  
 
FIGURE 10.  The C-terminal deletion mutant of TDP-43 still binds to UG12 RNA.  
(A) TDP-WT was in vitro translated in the presence of [35S]methionine (left lane, input) and was analyzed 
for binding to different RNA oligonucleotides immobilized on streptavidin beads (right lanes, UG12 = 
UGUGUGUGUGUGUGUGUGUGUGUG; GGUG = UUGUAUUUUGAGCUAGUUUGGUGAU; CCUC = 
UUGUAUUUUGAGCUAGUUUCCUCAU).  TDP-43 bound to both UG12 and GGUG RNA, but not to CCUC 
RNA. 
(B) The indicated TDP-43 constructs were in vitro translated in the presence of [35S]methionine (upper 
panel, input).  Biotinylated UG12 RNA or CCUC control RNA were immobilized on streptavidin beads and 
were used to pull down radioactively labeled proteins (lower panel, pulldown).  TDP-WT and NLSmut as 
well as the C-terminal deletion mutant NLSmut-C were specifically pulled down by UG12 RNA, whereas 
the 1-173 deletion mutant resembling the 25 kDa CTF did not bind to UG12 RNA.   
 
FIGURE 11.  Model of SG recruitment of TDP-43 and FUS. 
Upon cellular stress, translation of mRNAs is arrested and translationally silent preinitiation complexes that 
contain mRNA, the small ribosomal subunit (40S), early initiation factors (e.g. eIF3, eIF4A, eIF4G) and 
PABP-1 are packaged into stress granules (SG).  We suggest that recruitment of TDP-43 (left) or FUS 
(right) into SG involves both protein-RNA and protein-protein interactions.  TDP-43 and FUS bind to UG-
rich mRNA sequences via their main RNA binding domain (RRM1 in TDP-43 and RGG-zinc finger (Z) 
domain in FUS, respectively) and thus might be recruited into SG via their associated mRNAs.  Since 
additional domains that did not show binding to UG-rich RNA in our RNA binding assay, also contribute to 
SG recruitment of TDP-43 and FUS, we suggest that additional protein-protein interactions with proteins X 
and Y are involved in SG recruitment of TDP-43 and FUS.   
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